Chronic Leukemia Meeting Materials
The Chronic Leukemia Working Committee provides scientific oversight for studies related to hematopoietic cell transplantation for chronic leukemias, myelodysplastic disorders and myeloproliferative disorders. Studies related to cellular therapy evaluating chronic lymphocytic leukemia-specific questions or those aiming to compare cellular therapy approaches (e.g. CAR-T vs. allogeneic transplant) are also entertained in collaboration with the Cellular Immunotherapy for Cancer Working Committee.
Meetings are held annually during the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. Anyone with interest or expertise in the focus area is encouraged to attend.
The TCT® Trademark belongs to the Cardiovascular Research Foundation. ASTCT, CIBMTR, MCW, NMDP, the 2019, 2020, and 2021 TCT Conferences and materials are NOT affiliated with or sponsored by Cardiovascular Research Foundation.